HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients

被引:22
作者
Haukoos, Jason S. [1 ,2 ,3 ]
White, Douglas A. E. [4 ]
Rowan, Sarah E. [5 ,6 ]
Lyle, Carolynn [1 ]
Gravitz, Stephanie [1 ]
Basham, Kellie [4 ]
Godoy, Ashley [4 ]
Kamis, Kevin [6 ]
Hopkins, Emily [1 ,2 ]
Anderson, Erik [4 ]
机构
[1] Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA
[2] Univ Colorado, Dept Emergency Med, Sch Med, Aurora, CO USA
[3] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA
[4] Alameda Hlth Syst, Dept Emergency Med, Highland Hosp, Oakland, CA USA
[5] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA
[6] Denver Hlth, Denver Publ Hlth, Denver, CO USA
关键词
HIV; pre-exposure prophylaxis; prevalence; HIV risk; prevention; emergency department; identification; Denver HIV Risk Score; ANTIRETROVIRAL PROPHYLAXIS; INFECTION; IMPLEMENTATION; PREVENTION; VALIDATION; GUIDELINES; YOUNG; SCORE; NEED; MEN;
D O I
10.1089/apc.2021.0012
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our objective was to estimate the prevalence of pre-exposure prophylaxis (PrEP) eligibility, characterize self-perceived and quantified human immunodeficiency virus (HIV) risk, and assess PrEP knowledge and receptiveness of initiating PrEP among emergency department (ED) patients. We performed an IRB-approved cross-sectional study from two urban EDs. Patients were eligible if >= 18 years of age and not known to have HIV. Research staff obtained verbal consent and used a structured 29-item instrument to assess HIV risk, PrEP eligibility based on 2017 Centers for Disease Control and Prevention (CDC) guidelines, and general PrEP knowledge among unselected and enriched patient samples, the latter informed by the Denver HIV Risk Score (DHRS). We enrolled 1002 patients with a median age of 39 years; 54.8% were male, 30.9% White/non-Hispanic, 29.5% Black/non-Hispanic, and 22.5% Hispanic. In the full cohort, 119 [11.9%, 95% confidence interval (CI): 9.9-14.0%] were PrEP eligible, and among the unselected cohort, 36 (7.1%, 95% CI: 5.1-9.8%) were PrEP eligible. Using the DHRS, 100 patients were considered "high risk" with 32 (32.0%) reporting zero perceived risk. Correlation between the DHRS and self-perceived HIV risk was low (r = 0.13). Of the full cohort, 203 (20.3%) had heard of PrEP, and of these, 33 (16.3%) were PrEP eligible with 25 (75.8%) willing to start PrEP immediately. Yet, of the 119 patients who were PrEP eligible, only 34 (28.6%) had heard of PrEP. In summary, among a heterogeneous ED population, there was discordance in self-perceived and quantified HIV risk. HIV PrEP eligibility was similar to 7% with the highest eligibility among those identified as DHRS "high risk." A significant opportunity exists to identify and initiate PrEP among ED patients.
引用
收藏
页码:211 / 219
页数:9
相关论文
共 31 条
[1]  
[Anonymous], National Hospital Ambulatory Medical Care Survey: 2009 Emergency Department Summary Tables
[2]   Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].
Baeten, J. M. ;
Donnell, D. ;
Ndase, P. ;
Mugo, N. R. ;
Campbell, J. D. ;
Wangisi, J. ;
Tappero, J. W. ;
Bukusi, E. A. ;
Cohen, C. R. ;
Katabira, E. ;
Ronald, A. ;
Tumwesigye, E. ;
Were, E. ;
Fife, K. H. ;
Kiarie, J. ;
Farquhar, C. ;
John-Stewart, G. ;
Kakia, A. ;
Odoyo, J. ;
Mucunguzi, A. ;
Nakku-Joloba, E. ;
Twesigye, R. ;
Ngure, K. ;
Apaka, C. ;
Tamooh, H. ;
Gabona, F. ;
Mujugira, A. ;
Panteleeff, D. ;
Thomas, K. K. ;
Kidoguchi, L. ;
Krows, M. ;
Revall, J. ;
Morrison, S. ;
Haugen, H. ;
Emmanuel-Ogier, M. ;
Ondrejcek, L. ;
Coombs, R. W. ;
Frenkel, L. ;
Hendrix, C. ;
Bumpus, N. N. ;
Bangsberg, D. ;
Haberer, J. E. ;
Stevens, W. S. ;
Lingappa, J. R. ;
Celum, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410
[3]   Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP [J].
Calabrese, Sarah K. ;
Willie, Tiara C. ;
Galvao, Rachel W. ;
Tekeste, Mehrit ;
Dovidio, John F. ;
Safon, Cara B. ;
Blackstock, Oni ;
Taggart, Tamara ;
Kaplan, Clair ;
Caldwell, Abigail ;
Kershaw, Trace S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (04) :395-405
[4]  
*CDCP, 2018, HIV AIDS BAS STAT
[5]  
Centers for Disease Control and Prevention, 2020, END HIV EP
[6]  
Centers for Disease Control and Prevention, 2017, US PUBL HLTH SERV PR
[7]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[8]   Preexposure Prophylaxis for the Prevention of HIV Infection Evidence Report and Systematic Review for the US Preventive Services Task Force [J].
Chou, Roger ;
Evans, Christopher ;
Hoverman, Adam ;
Sun, Christina ;
Dana, Tracy ;
Bougatsos, Christina ;
Grusing, Sara ;
Korthuis, P. Todd .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (22) :2214-2230
[9]   Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. [J].
Grant, Robert M. ;
Lama, Javier R. ;
Anderson, Peter L. ;
McMahan, Vanessa ;
Liu, Albert Y. ;
Vargas, Lorena ;
Goicochea, Pedro ;
Casapia, Martin ;
Guanira-Carranza, Juan Vicente ;
Ramirez-Cardich, Maria E. ;
Montoya-Herrera, Orlando ;
Fernandez, Telmo ;
Veloso, Valdilea G. ;
Buchbinder, Susan P. ;
Chariyalertsak, Suwat ;
Schechter, Mauro ;
Bekker, Linda-Gail ;
Mayer, Kenneth H. ;
Kallas, Esper Georges ;
Amico, K. Rivet ;
Mulligan, Kathleen ;
Bushman, Lane R. ;
Hance, Robert J. ;
Ganoza, Carmela ;
Defechereux, Patricia ;
Postle, Brian ;
Wang, Furong ;
McConnell, J. Jeff ;
Zheng, Jia-Hua ;
Lee, Jeanny ;
Rooney, James F. ;
Jaffe, Howard S. ;
Martinez, Ana I. ;
Burns, David N. ;
Glidden, David V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (27) :2587-2599
[10]   Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States [J].
Grohskopf, Lisa A. ;
Chillag, Kata L. ;
Gvetadze, Roman ;
Liu, Albert Y. ;
Thompson, Melanie ;
Mayer, Kenneth H. ;
Collins, Brandi M. ;
Pathak, Sonal R. ;
O'Hara, Brandon ;
Ackers, Marta L. ;
Rose, Charles E. ;
Grant, Robert M. ;
Paxton, Lynn A. ;
Buchbinder, Susan P. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (01) :79-86